2020 annual financial data
Halozyme Therapeutics 2020 Revenue growth
Direct answer
Revenue growth was 36.53%.
Operating income was 144,255,000 USD and net income was 129,085,000 USD.
Operating cash flow was 55,454,000 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 267,594,000 USD
- Operating income
- 144,255,000 USD
- Net income
- 129,085,000 USD
- Operating cash flow
- 55,454,000 USD